Transient Benefit in Outcomes Seen With Androgen Suppression + RT for Prostate Cancer

WEDNESDAY, May 24, 2023 -- For patients with intermediate-risk prostate cancer, adding total androgen suppression (TAS) to dose-escalated radiation therapy (RT) yields transient clinically meaningful declines in Expanded Prostate Cancer Index...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news